Saturday, October 31, 2026

China Yuchai International Limited And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

China Yuchai International Limited  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - China Yuchai International Limited (CYD), QUALCOMM (QCOM), ANSYS (ANSS) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. China Yuchai International Limited (CYD)

37.5% sales growth and 6.66% return on equity

China Yuchai International Limited, through its subsidiaries, manufactures and sells diesel and natural gas engines in the People's Republic of China and internationally.

China Yuchai International Limited's sales growth this year is expected to be 25.7% and a negative 4.1% for next year.

Year-on-year quarterly revenue growth declined by 6.5%, now sitting on 20.58B for the twelve trailing months.

Volume

Today's last reported volume for China Yuchai International Limited is 2800 which is 94.16% below its average volume of 47979.

China Yuchai International Limited's sales growth is a negative 0% for the current quarter and 37.5% for the next. The company's growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.66%.

Volatility

China Yuchai International Limited's last day, last week, and last month's current volatility was 0.41%, 1.27%, and 1.29%, respectively.

China Yuchai International Limited's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.36% (day), 2.89% (last week), and 2.71% (last month), respectively.

China Yuchai International Limited's Stock Yearly Top and Bottom Value

China Yuchai International Limited's stock is valued at $14.61 at 20:22 EST, way under its 52-week high of $20.49 and above its 52-week low of $13.41.

China Yuchai International Limited's Moving Average

China Yuchai International Limited's value is under its 50-day moving average of $16.18 and below its 200-day moving average of $16.19.

2. QUALCOMM (QCOM)

30.2% sales growth and 153.25% return on equity

QUALCOMM Incorporated designs, develops, manufactures, and markets digital communication products worldwide.

QUALCOMM's sales growth this year is anticipated to be 48.5% and 9% for next year.

Year-on-year quarterly revenue growth grew by 52.1%, now sitting on 29.41B for the twelve trailing months.

Volume

Today's last reported volume for QUALCOMM is 5976280 which is 24.33% below its average volume of 7897390.

QUALCOMM's sales growth is a negative 0% for the present quarter and 30.2% for the next. The company's growth estimates for the ongoing quarter and the next is 94.2% and 40%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 153.25%.

Volatility

QUALCOMM's last day, last week, and last month's current volatility was 0.79%, 2.13%, and 1.43%, respectively.

QUALCOMM's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.38% (day), 2.36% (last week), and 2.08% (last month), respectively.

QUALCOMM's Stock Yearly Top and Bottom Value

QUALCOMM's stock is valued at $147.95 at 20:22 EST, way below its 52-week high of $167.94 and way higher than its 52-week low of $104.74.

QUALCOMM's Moving Average

QUALCOMM's value is above its 50-day moving average of $140.29 and above its 200-day moving average of $139.04.

3. ANSYS (ANSS)

9.5% sales growth and 12.43% return on equity

ANSYS, Inc. develops and markets engineering simulation software and services worldwide.

ANSYS's sales growth this year is anticipated to be 9.4% and 10.3% for next year.

Year-on-year quarterly revenue growth grew by 19.1%, now sitting on 1.74B for the twelve trailing months.

Volume

Today's last reported volume for ANSYS is 275016 which is 30.09% below its average volume of 393393.

ANSYS's sales growth is a negative 0% for the current quarter and 9.5% for the next. The company's growth estimates for the present quarter and the next is 0.6% and negative -2.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.43%.

Volatility

ANSYS's last day, last week, and last month's current volatility was 0.85%, 0.78%, and 0.85%, respectively.

ANSYS's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.59% (day), 1.59% (last week), and 1.88% (last month), respectively.

ANSYS's Stock Yearly Top and Bottom Value

ANSYS's stock is valued at $370.82 at 20:22 EST, way under its 52-week high of $413.19 and way above its 52-week low of $292.79.

ANSYS's Moving Average

ANSYS's value is higher than its 50-day moving average of $349.73 and higher than its 200-day moving average of $350.21.

4. El Pollo Loco Holdings (LOCO)

6.4% sales growth and 9.35% return on equity

El Pollo Loco Holdings, Inc., through its subsidiary El Pollo Loco, Inc., develops, franchises, licenses, and operates quick-service restaurants under the El Pollo Loco name.

El Pollo Loco Holdings's sales growth this year is expected to be 7.3% and 4.6% for next year.

Year-on-year quarterly revenue growth grew by 2.4%, now sitting on 428.64M for the twelve trailing months.

Volume

Today's last reported volume for El Pollo Loco Holdings is 66160 which is 67.08% below its average volume of 200966.

El Pollo Loco Holdings's sales growth for the next quarter is 6.4%. The company's growth estimates for the current quarter and the next is 35% and negative -14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.35%.

Volatility

El Pollo Loco Holdings's last day, last week, and last month's current volatility was 1.72%, 0.74%, and 0.97%, respectively.

El Pollo Loco Holdings's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.36% (day), 2.59% (last week), and 2.60% (last month), respectively.

El Pollo Loco Holdings's Stock Yearly Top and Bottom Value

El Pollo Loco Holdings's stock is valued at $18.61 at 20:22 EST, way under its 52-week high of $21.96 and way higher than its 52-week low of $13.95.

El Pollo Loco Holdings's Moving Average

El Pollo Loco Holdings's value is higher than its 50-day moving average of $18.11 and higher than its 200-day moving average of $18.14.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com